核心药物四季度销售增长低于预期,礼来股价大跌,加速全球扩产

第一财经
15 Jan

美东时间1月14日,礼来(LLY.US)美股股价盘中一度下挫逾8%,截至当天收盘时,股价仍跌6.59%。直接的导火线是礼来2024年第四季度的营业收入增速不及预期。礼来预计2024年全年营收同比增长32%至450亿美元,但其中的2024年第四季度营收预计同比增长45%至135亿美元,该营收较近期发布的财务指引下限低约4亿美元。作为一款GIP(葡萄糖依赖性促胰岛素多肽)和GLP-1(胰高糖素样肽-1...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10